BIOMAT Database Logo BIOMAT Database Logo

Roentgenographic changes during long-term diphenylhydantoin therapy. 1980

E S McCrea, and C V Rao, and J N Diaconis

Diphenylhydantoin (Dilantin) is a well known anticonvulsant with well documented effectiveness. The complications, unfortunately, are multiple and well recognized clinically. This paper deals with the roentgenographic changes encountered in long-term diphenylhydantoin use. Some of these changes, which are not clinically readily apparent, may alert unwary physicians in the recognition of diphenylhydantoin-induced disease.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008206 Lymphatic Diseases Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS. Lymphatism,Status Lymphaticus,Disease, Lymphatic,Diseases, Lymphatic,Lymphatic Disease
D010018 Osteomalacia Disorder caused by an interruption of the mineralization of organic bone matrix leading to bone softening, bone pain, and weakness. It is the adult form of rickets resulting from disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis. Adult Rickets,Rickets, Adult
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D001847 Bone Diseases Diseases of BONES. Bone Disease,Disease, Bone,Diseases, Bone
D002526 Cerebellar Diseases Diseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA. Cerebellar Dysfunction,Cerebellum Diseases,Cerebellar Disorders,Cerebellar Syndromes,Cerebellar Disease,Cerebellar Disorder,Cerebellar Dysfunctions,Cerebellar Syndrome,Cerebellum Disease,Disease, Cerebellar,Disease, Cerebellum,Disorder, Cerebellar,Dysfunction, Cerebellar,Syndrome, Cerebellar
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000014 Abnormalities, Drug-Induced Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment. Drug-Induced Abnormalities,Abnormalities, Drug Induced,Abnormality, Drug-Induced,Drug Induced Abnormalities,Drug-Induced Abnormality

Related Publications

E S McCrea, and C V Rao, and J N Diaconis
Thyroxine, triiodothyronine, and thyrotropin in serum during long-term diphenylhydantoin therapy.
March 1976, Scandinavian journal of clinical and laboratory investigation,
E S McCrea, and C V Rao, and J N Diaconis
Peripheral neuropathy in long-term diphenylhydantoin therapy.
January 1967, Transactions of the American Neurological Association,
E S McCrea, and C V Rao, and J N Diaconis
[Myasthenic syndrome following long-term diphenylhydantoin therapy].
August 1983, Der Nervenarzt,
E S McCrea, and C V Rao, and J N Diaconis
Peripheral neuropathy in long-term diphenylhydantoin therapy.
January 1968, Archives of neurology,
E S McCrea, and C V Rao, and J N Diaconis
[Control of long-term therapy with diphenylhydantoin. Gas-chromatographic determination of diphenylhydantoin and hydroxy-diphenylhydantoin].
May 1973, Zeitschrift fur Neurologie,
E S McCrea, and C V Rao, and J N Diaconis
Abnormalities in liver function tests during long-term diphenylhydantoin therapy in epileptic out-patients.
October 1973, Acta medica Scandinavica,
E S McCrea, and C V Rao, and J N Diaconis
Potassium-level changes during long-term thiazide therapy.
January 1978, Comprehensive therapy,
E S McCrea, and C V Rao, and J N Diaconis
Renal hemodynamic changes during long-term antihypertensive therapy.
March 1981, Clinical pharmacology and therapeutics,
E S McCrea, and C V Rao, and J N Diaconis
Nerve conduction velocity in patients on long-term diphenylhydantoin therapy.
June 1974, Epilepsia,
E S McCrea, and C V Rao, and J N Diaconis
Changes in HIV reservoirs during long-term antiretroviral therapy.
January 2015, Current opinion in HIV and AIDS,
Copied contents to your clipboard!